Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background Psychosocial outcomes from the Prevention of Recurrent Episodes of Depression with Venlafaxine ER for Two Years (PREVENT) study were evaluated. Methods Adult outpatients with recurrent major depressive disorder (MDD) and response or remission following 6-month continuation treatment with venlafaxine extended release (ER) were randomized to receive venlafaxine ER or placebo for 1 year. Patients without recurrence on venlafaxine ER during year 1 were randomized to venlafaxine ER or placebo for year 2. Psychosocial functioning was assessed using the Quality of Life Enjoyment and Satisfaction Questionnaire—Short Form (Q-LES-Q), Life EnjoymentScale—Short Version (LES-S), Social Adjustment Scale—Self-Report (SAS-SR) total and individual factors, Short Form Health Survey (SF-36) (vitality, social functioning, and role function-emotional items), and Longitudinal Interval Follow-up Evaluation (LIFE). Results At year 1 end, better overall psychosocial functioning was seen among patients randomly assigned to venlafaxine ER (n=129) vs placebo (n=129), with significant differences at end point on SF-36 role function-emotional, Q-LES-Q, and SAS-SR total, and work, house work, social/leisure, and extended-family factor scores (p≤0.05). At year 2 end, significant differences favored venlafaxine ER (n=43) vs placebo (n=40)on SF-36 vitality and rolefunction-emotional, Q-LES-Q, LES-S, LIFE, and SAS-SR total, social/leisure, and extended-family factor scores (p≤0.05). Limitations Patients with chronic MDD or treatment resistance were excluded and long-term specialist care was a financial incentive for treatment compliance. Discontinuation-related adverse events may have compromised the integrity of the treatment blind. Conclusions For patients with recurrent MDD, 2 years’ maintenance therapy with venlafaxine ER may improve psychosocial functioning vs placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessment of social adjustment by patient self report.
Weissman, M. M. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090101010 · Cited by 1,782 · cited 4×
“SAS-SR The SAS-SR is a self-rated scale that assesses functioning across 9 domains, including work, housework, student/ academic, social/leisure, extended family, marital, sexual dysfunction, parental, and family unit, as well as generating a total adjustment score (Weissman and Bothwell, 1976).”
InfluentialKeller, M. B. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180050009 · Cited by 1,643
Self-citationThe Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000?
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., & Corey-Lisle, P. K. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1211 · Cited by 1,280
TRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968
Self-citationSocial adjustment by self-report in a community sample and in psychiatric outpatients
WEISSMAN, M. M., PRUSOFF, B. A., THOMPSON, W. D., HARDING, P. S., & MYERS, J. K. (1978) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197805000-00002 · Cited by 537 · cited 1×
“In one study, mean SAS-SR total score (SD) in a community sample was 1.60 (0.33) (Weissman et al., 1978).”
InfluentialJudd, L. L., Schettler, P. J., Solomon, D. A., Maser, J. D., Coryell, W., Endicott, J., & Akiskal, H. S. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.06.014 · Cited by 293 · cited 6×
“Prospective, naturalistic, longitudinal studies of patients with MDD have allowed us to better understand the course, nature, and magnitude of psychosocial impairments seen in patients with MDD (Judd et al., 2000, 2008; Kennedy et al., 2007; Solomon et al., 2004; Vittengl et al., 2009).”
InfluentialHirschfeld, R. M. A., Dunner, D. L., Keitner, G., Klein, D. N., Koran, L. M., Kornstein, S. G., Markowitz, J. C., Miller, I., Nemeroff, C. B., Ninan, P. T., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01291-4 · Cited by 231
Self-citationKeller, M. B., Trivedi, M. H., Thase, M. E., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Kocsis, J. H., Dunner, D. L., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0812 · Cited by 116
Self-citationKocsis, J. H., Thase, M. E., Trivedi, M. H., Shelton, R. C., Kornstein, S. G., Nemeroff, C. B., Friedman, E. S., Gelenberg, A. J., Dunner, D. L., Hirschfeld, R. M. A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0706 · Cited by 67
Self-citation
Research works printed but not linked: 25
- Daly, 2010, Health related quality of life in depression: a STAR*D report, Ann. Clin. Psychiatry, 22, 43, 10.1177/104012371002200107 · DOI · Paper page
- Endicott, 1993, Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure, Psychopharmacol. Bull., 29, 321
- Fawcett, 1983, Assessing anhedonia in psychiatric patients, Arch. Gen. Psychiatry, 40, 79, 10.1001/archpsyc.1983.01790010081010 · DOI · Paper page
- Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Jarrett, 2001, Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial, Arch. Gen. Psychiatry, 58, 381, 10.1001/archpsyc.58.4.381 · DOI · Paper page
- Judd, 2000, Psychosocial disability during the long-term course of unipolar major depressive disorder, Arch. Gen. Psychiatry, 57, 375, 10.1001/archpsyc.57.4.375 · DOI · Paper page
- Keitner, 1995, Role of the family in recovery and major depression, Am. J. Psychiatry, 152, 1002, 10.1176/ajp.152.7.1002 · DOI · Paper page
- Keller, 2007, The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two years (PREVENT) study: outcomes from the acute and continuation phases, Biol. Psychiatry, 62, 1371, 10.1016/j.biopsych.2007.04.040 · DOI
- Kennedy, 2007, Long-term social functioning after depression treated by psychiatrists: a review, Bipolar Disord., 9, 25, 10.1111/j.1399-5618.2007.00326.x · DOI · Paper page
- Kessler, 2003, The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R), JAMA, 289, 3095, 10.1001/jama.289.23.3095 · DOI · Paper page
- Kocsis, 2002, Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo, Arch. Gen. Psychiatry, 59, 723, 10.1001/archpsyc.59.8.723 · DOI · Paper page
- Kornstein, 2006, Beyond remission: rationale and design of the Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study, CNS Spectr., 10.1017/S1092852900015236 · DOI
- Lenze, 2002, Combined pharmacotherapy and psychotherapy as maintenance treatment for late-life depression: effects on social adjustment, Am. J. Psychiatry, 159, 466, 10.1176/appi.ajp.159.3.466 · DOI
- McHorney, 1994, Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey, Med. Care, 32, 551, 10.1097/00005650-199406000-00002 · DOI · Paper page
- Miller, 1998, The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine, J. Clin. Psychiatry, 59, 608, 10.4088/JCP.v59n1108 · DOI · Paper page
- Papakostas, 2004, Psychosocial functioning during the treatment of major depressive disorder with fluoxetine, J. Clin. Psychopharmacol., 24, 507, 10.1097/01.jcp.0000138761.85363.d5 · DOI · Paper page
- Pettit, 2009, The long-term course of depression: development of an empirical index and identification of early adult outcomes, Psychol. Med., 39, 403, 10.1017/S0033291708003851 · DOI · Paper page
- Schechter, 2007, Quality of life of ‘normal’ controls: association with lifetime history of mental illness, Psychiatry Res., 152, 45, 10.1016/j.psychres.2006.09.008 · DOI
- Solomon, 2004, Psychosocial impairment and recurrence of major depression, Compr. Psychiatry, 45, 423, 10.1016/j.comppsych.2004.07.002 · DOI
- Trivedi, 2001, Sensitizing clinicians and patients to the social and functional aspects of remission, J. Clin. Psychiatry, 62, 32
- Trivedi, 2006, Factors associated with health-related quality of life among outpatients with major depressive disorder: a STAR*D report, J. Clin. Psychiatry, 67, 185, 10.4088/JCP.v67n0203 · DOI · Paper page
- Trivedi, 2008, REVAMP—research evaluating the value of augmenting medication with psychotherapy: rationale and design, Psychopharmacol. Bull., 41, 5
- Vittengl, 2009, Deterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depression, J. Affect. Disord., 112, 135, 10.1016/j.jad.2008.04.004 · DOI
- Ware, 1996, A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity, Med. Care, 34, 220, 10.1097/00005650-199603000-00003 · DOI · Paper page
- Wisniewski, 2007, Comparison of quality of life measures in a depressed population, J. Nerv. Ment. Dis., 195, 219, 10.1097/01.nmd.0000258229.38212.6f · DOI
Cited by
Kennedy, S. H., Lam, R. W., McIntyre, R. S., Tourjman, S. V., Bhat, V., Blier, P., Hasnain, M., Jollant, F., Levitt, A. J., MacQueen, G. M., et al. (2016) · The Canadian Journal of Psychiatry · doi:10.1177/0706743716659417 · Cited by 1,181
Fluoxetine versus other types of pharmacotherapy for depression
Magni, L. R., Purgato, M., Gastaldon, C., Papola, D., Furukawa, T. A., Cipriani, A., & Barbui, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004185.pub3 · Cited by 252
Restoring function in major depressive disorder: A systematic review
Sheehan, D. V., Nakagome, K., Asami, Y., Pappadopulos, E. A., & Boucher, M. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.029 · Cited by 182
Van Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Florea, I., Danchenko, N., Brignone, M., Loft, H., Rive, B., & Abetz-Webb, L. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.08.008 · Cited by 35
Number of illness episodes as predictor of residual symptoms in major depressive disorder
Serafini, G., Nebbia, J., Cipriani, N., Conigliaro, C., Erbuto, D., Pompili, M., & Amore, M. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2017.09.026 · Cited by 11
Metadata
- Authors
- Trivedi, M. H., Dunner, D. L., Kornstein, S. G., Thase, M. E., Zajecka, J. M., Rothschild, A. J., Friedman, E. S., Shelton, R. C., Keller, M. B., Kocsis, J. H., & Gelenberg, A.
- Venue
- Journal of Affective Disorders
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 126
- Issue
- 3
- Pages
- 420-429
- ISSN
- 0165-0327 (ISSN-L)
- OpenAlex
- W2127790797
- Cited by
- 36
- References
- 10
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.